Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| VTRS | Viatris Inc | 2026-03-03 12:10:57 | 14.97 | -0.73 | -4.68 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VTRS | 0001792044 | Viatris Inc | US92556V1061 | 254900ZZTSW7NL773X71 | 834364296 | Nasdaq | 2834 | Pharmaceutical Preparations | 1231 | DE | 1000 MYLAN BOULEVARD | CANONSBURG | PA | 15317 | UNITED STATES | US | (724) 514-1465 | 1000 MYLAN BOULEVARD, CANONSBURG, PA, 15317 | 1000 MYLAN BOULEVARD, CANONSBURG, PA, 15317 | Upjohn Inc | Pharmaceuticals | 2020-11-16 | Scott A. Smith | 32,000 | http://viatris.com | 12,661,582,065 | 100 | 1,151,769,872 | Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. | 2026-02-26 15:50:17 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 10,384,706,269 | -2,276,875,796 | -17.9826 | 1,151,392,922 | -34,463,530 | -2.9062 |
| 2024 | 12,661,582,065 | 724,869,483 | 6.0726 | 1,185,856,452 | -4,805,947 | -0.4036 |
| 2023 | 11,936,712,582 | -725,415,409 | -5.729 | 1,190,662,399 | -8,345,782 | -0.6961 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Corinne Le Goff | Chief Commercial Officer | 2024 | 605,769 | 0 | 4,375,019 | 873,566 | 61,040 | 5,915,394 |
| Paul Campbell | Chief Accounting Officer, Corporate Controller | 2024 | 715,385 | 1,750,000 | 1,812,507 | 1,015,000 | 222,398 | 5,515,290 |
| Scott A. Smith | Chief Executive Officer | 2024 | 1,400,000 | 0 | 9,800,021 | 2,940,000 | 619,358 | 14,759,379 |
| Doretta Mistras | Chief Financial Officer | 2024 | 809,135 | 500,000 | 3,800,019 | 1,155,000 | 109,538 | 6,373,692 |
| Brian Roman | Chief Legal Officer | 2024 | 824,520 | 0 | 2,475,004 | 1,155,000 | 234,780 | 4,689,304 |
| Fiscal Year | Employee Count |
|---|---|
| 2020 | 45,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 14,299,900,000 | 14,739,300,000 | 15,426,900,000 |
| Cost Of Revenue | 9,286,400,000 | 9,115,700,000 | 8,988,300,000 |
| Gross Profit | 5,013,500,000 | 5,623,600,000 | 6,438,600,000 |
| Research And Development Expenses | 965,900,000 | 808,700,000 | 805,200,000 |
| General And Administrative Expenses | 3,794,100,000 | 4,425,600,000 | 4,650,100,000 |
| Operating Expenses | 7,676,600,000 | 5,613,500,000 | 5,672,400,000 |
| Operating Income | -2,663,100,000 | 10,100,000 | 766,200,000 |
| Net Income | -3,514,900,000 | -634,200,000 | 54,700,000 |
| Earnings Per Share Basic | -3 | -0.53 | 0.05 |
| Earnings Per Share Diluted | -3 | -0.53 | 0.05 |
| Weighted Average Shares Outstanding Basic | 1,171,633,333 | 1,196,603,773 | 1,094,000,000 |
| Weighted Average Shares Outstanding Diluted | 1,171,633,333 | 1,196,603,773 | 1,094,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,322,400,000 | 734,800,000 | 991,900,000 |
| Marketable Securities Current | 40,700,000 | 38,000,000 | 37,000,000 |
| Accounts Receivable | 2,577,600,000 | 2,675,300,000 | 2,823,800,000 |
| Inventories | 3,999,200,000 | 3,854,100,000 | 3,469,700,000 |
| Non Trade Receivables | 315,800,000 | 300,700,000 | 340,200,000 |
| Other Assets Current | 136,200,000 | 387,200,000 | 271,000,000 |
| Total Assets Current | 9,789,200,000 | 9,520,700,000 | 12,976,100,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,614,000,000 | 2,666,100,000 | 2,759,600,000 |
| Other Assets Non Current | 1,871,900,000 | 2,356,900,000 | 2,208,700,000 |
| Total Assets Non Current | 27,403,900,000 | 31,980,200,000 | 34,709,400,000 |
| Total Assets | 37,193,100,000 | 41,500,900,000 | 47,685,500,000 |
| Accounts Payable | 1,754,100,000 | 1,853,700,000 | 1,938,200,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 1,929,900,000 | 600,000 | 1,934,700,000 |
| Other Liabilities Current | 3,282,900,000 | 3,724,700,000 | 3,393,900,000 |
| Total Liabilities Current | 7,094,300,000 | 5,779,400,000 | 7,777,400,000 |
| Long Term Debt | 12,480,600,000 | 14,038,900,000 | 16,188,100,000 |
| Other Liabilities Non Current | 2,014,900,000 | 1,939,200,000 | 1,516,900,000 |
| Total Liabilities Non Current | 15,387,500,000 | 17,086,000,000 | 19,440,700,000 |
| Total Liabilities | 22,481,800,000 | 22,865,400,000 | 27,218,100,000 |
| Common Stock | 12,500,000 | 12,300,000 | 12,200,000 |
| Retained Earnings | -388,300,000 | 3,418,800,000 | 4,639,700,000 |
| Accumulated Other Comprehensive Income | -2,707,000,000 | -3,212,900,000 | -2,747,400,000 |
| Total Shareholders Equity | 14,711,300,000 | 18,635,500,000 | 20,467,400,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 2,423,700,000 | 2,536,100,000 | 2,349,100,000 |
| Share Based Compensation Expense | 177,700,000 | 146,100,000 | 180,700,000 |
| Other Non Cash Income Expense | -969,300,000 | -297,700,000 | -595,400,000 |
| Change In Accounts Receivable | -334,600,000 | -300,100,000 | -78,600,000 |
| Change In Inventories | 106,400,000 | 723,400,000 | 613,300,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -168,000,000 | 36,000,000 | 314,700,000 |
| Change In Other Liabilities | 633,700,000 | 150,600,000 | 414,600,000 |
| Cash From Operating Activities | 2,315,900,000 | 2,302,900,000 | 2,799,600,000 |
| Purchases Of Marketable Securities | 23,900,000 | 26,000,000 | 26,300,000 |
| Sales Of Marketable Securities | 23,900,000 | 26,000,000 | 26,300,000 |
| Acquisition Of Property Plant And Equipment | 378,800,000 | 326,000,000 | 377,000,000 |
| Acquisition Of Business | 0 | 350,000,000 | 667,700,000 |
| Other Investing Activities | 35,500,000 | 20,800,000 | 97,500,000 |
| Cash From Investing Activities | -427,700,000 | 1,800,700,000 | -764,100,000 |
| Tax Withholding For Share Based Compensation | 30,200,000 | 53,300,000 | 38,200,000 |
| Payments Of Dividends | 577,100,000 | 586,700,000 | 590,600,000 |
| Issuance Of Common Stock | 2,600,000 | 2,500,000 | 3,100,000 |
| Repurchase Of Common Stock | 500,500,000 | 250,000,000 | 250,000,000 |
| Issuance Of Long Term Debt | 0 | 0 | 300,000 |
| Repayment Of Long Term Debt | 100,000 | 3,713,700,000 | 1,250,200,000 |
| Other Financing Activities | -190,100,000 | 295,200,000 | -173,000,000 |
| Cash From Financing Activities | -1,293,900,000 | -4,330,400,000 | -2,301,900,000 |
| Change In Cash | 611,900,000 | -257,500,000 | -268,900,000 |
| Cash At End Of Period | 1,322,400,000 | 734,800,000 | 991,900,000 |
| Income Taxes Paid | 445,400,000 | 514,000,000 | 570,900,000 |
| Interest Paid | 492,600,000 | 561,100,000 | 611,600,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -3 | -0.53 | 0.05 |
| Price To Earnings Ratio | -4.15 | -23.4906 | 216.6 |
| Earnings Growth Rate | 466.0377 | -1,160 | -97.076 |
| Price Earnings To Growth Ratio | -0.0089 | 0.0203 | -2.2312 |
| Book Value Per Share | 12.5562 | 15.5737 | 18.7088 |
| Price To Book Ratio | 0.9915 | 0.7994 | 0.5789 |
| Ebitda | -174,500,000 | 2,965,900,000 | 3,547,800,000 |
| Enterprise Value | 27,674,934,995.85 | 28,202,416,973.85 | 28,978,920,000 |
| Dividend Yield | 0.0396 | 0.0394 | 0.0498 |
| Dividend Payout Ratio | -0.1642 | -0.9251 | 10.7971 |
| Debt To Equity Ratio | 0.9796 | 0.7534 | 0.8854 |
| Capital Expenditures | 2,371,600,000 | 2,442,600,000 | 2,084,200,000 |
| Free Cash Flow | -55,700,000 | -139,700,000 | 715,400,000 |
| Return On Equity | -0.2389 | -0.034 | 0.0027 |
| One Year Beta | 0.8044 | 0.5579 | 0.8111 |
| Three Year Beta | 0.7436 | 0.7622 | 0.7985 |
| Five Year Beta | 0.7711 | 0.7652 | 0.8034 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Mistras Theodora | Chief Financial Officer | 2026-01-01 | 23,085 | A | 48,265 |
| Mistras Theodora | Chief Financial Officer | 2026-01-01 | 13,395 | D | 34,870 |
| Mistras Theodora | Chief Financial Officer | 2026-01-01 | 2,175 | A | 37,045 |
| Mistras Theodora | Chief Financial Officer | 2026-01-01 | 1,203 | D | 35,842 |
| Mistras Theodora | Chief Financial Officer | 2026-01-01 | 23,085 | D | 0 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H Tuberville | Senator | 2022-09-15 | Sale (Full) | 2022-08-01 | Self | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2022-02-14 | Sale (Full) | 2022-01-13 | Joint | $1,001 - $15,000 |
| Thomas R Carper | Senator | 2021-01-07 | Sale (Full) | 2020-12-30 | Spouse | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | 2025-12-15 | CA31 | Purchase | 2025-11-18 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-05-08 | PA08 | Sale | 2025-04-08 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-04-07 | CA31 | Sale (Partial) | 2025-03-31 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-03-27 | PA08 | Purchase | 2025-02-25 | — | $1,001 - $15,000 |
| Daniel Goldman | 2023-05-19 | NY10 | Sale (Partial) | 2023-04-10 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Strategic Investment Solutions, Inc. /IL | 2025-12-31 | 13,780 | 1,107 | 12.4481 |
| GROUPAMA ASSET MANAGMENT | 2025-12-31 | 147,806 | 11,872 | 12.45 |
| Anchor Investment Management, LLC | 2025-12-31 | 16,430 | 1,320 | 12.447 |
| TD Capital Management LLC | 2025-12-31 | 721 | 58 | 12.431 |
| Bell Investment Advisors, Inc | 2025-12-31 | 4,296 | 345 | 12.4522 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| MASSMUTUAL SELECT FUNDS | 2025-12-31 | Service Class | MDVYX | 55,200 | 687,240 | 0.1522 |
| MASSMUTUAL SELECT FUNDS | 2025-12-31 | Class R5 | MDVSX | 55,200 | 687,240 | 0.1522 |
| MASSMUTUAL SELECT FUNDS | 2025-12-31 | Class R3 | MDVNX | 55,200 | 687,240 | 0.1522 |
| MASSMUTUAL SELECT FUNDS | 2025-12-31 | Administrative Class | MDDLX | 55,200 | 687,240 | 0.1522 |
| MASSMUTUAL SELECT FUNDS | 2025-12-31 | Class A | MDDAX | 55,200 | 687,240 | 0.1522 |